Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 17 (5) , 622-632
- https://doi.org/10.1007/s10156-011-0219-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- AspergillosisNew England Journal of Medicine, 2009
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Treatment of Invasive Candidal Infections: Systematic Review and Meta-analysisMayo Clinic Proceedings, 2008
- Role of micafungin in the antifungal armamentarium.Current Medicinal Chemistry, 2007
- Clinical efficacy of micafungin for chronic pulmonary aspergillosisMedical Mycology, 2007
- Micafungin: A New EchinocandinClinical Infectious Diseases, 2006
- Epidemiology of Visceral Mycoses in Patients with Leukemia and MDS-Analysis of the Data in Annual of Pathological Autopsy Cases in Japan in 1989, 1993, 1997 and 2001-Japanese journal of medical mycology, 2006
- A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in JapanScandinavian Journal of Infectious Diseases, 2004
- MicafunginDrugs, 2004
- Recent trends in the epidemiology of invasive mycosesCurrent Opinion in Infectious Diseases, 2002